Purdue Pharma squares off with DOJ Over $6 billion OxyContin deal
A $6 billion deal hangs in the balance as OxyContin maker Purdue Pharma LP and its wealthy owners square off against the U.S. Justice Department over the firm’s opioid lawsuit settlement.
Tribune News Service ·